KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Scotts Miracle-Gro (SMG) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Scotts Miracle-Gro (SMG) over the last 17 years, with Q4 2025 value amounting to $264.4 million.

  • Scotts Miracle-Gro's Cost of Revenue fell 444.52% to $264.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year decrease of 965.22%. This contributed to the annual value of $2.3 billion for FY2025, which is 1031.43% down from last year.
  • Per Scotts Miracle-Gro's latest filing, its Cost of Revenue stood at $264.4 million for Q4 2025, which was down 444.52% from $359.6 million recorded in Q3 2025.
  • Over the past 5 years, Scotts Miracle-Gro's Cost of Revenue peaked at $1.2 billion during Q2 2021, and registered a low of $264.4 million during Q4 2025.
  • Moreover, its 5-year median value for Cost of Revenue was $609.1 million (2021), whereas its average is $677.2 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first skyrocketed by 7629.3% in 2021, then tumbled by 2193.4% in 2022.
  • Quarter analysis of 5 years shows Scotts Miracle-Gro's Cost of Revenue stood at $609.1 million in 2021, then crashed by 30.95% to $420.6 million in 2022, then dropped by 15.83% to $354.0 million in 2023, then dropped by 21.84% to $276.7 million in 2024, then decreased by 4.45% to $264.4 million in 2025.
  • Its last three reported values are $264.4 million in Q4 2025, $359.6 million for Q3 2025, and $806.3 million during Q2 2025.